EyePoint Pharma Secures $45M Credit Facilities For Debt Refinancing

  • EyePoint Pharmaceuticals Inc EYPT has secured senior secured credit facilities of $45 million from Silicon Valley Bank to replace its existing credit facility with CRG Servicing LLC
  • Under the terms of the new agreement, a $30 million term loan facility and an asset-based revolving credit facility of up to $15 million will replace the existing approximately $40.5 million of obligations under the existing CRG credit facility. 
  • The new facility reduces the loan interest rate from 12.5% to a blended rate of approximately 5%, resulting in an estimated $2.8 million of annualized interest savings.
  • Related: EyePoint Pharmaceuticals Raises $100M Via Capital Raise At 5% Discount.
  • As of December 31, 2021, the Company had $211.6 million in cash and investments, including over $230 million in proceeds from two follow-on equity offerings during 2021.
  • Price Action: EYPT shares traded 1.44% higher at $13.36 on the last check Wednesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechNewsHealth CareFinancingSmall CapGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!